Effect of nanoparticles coated with different modifications of dextran on lysozyme amyloid aggregation
Source abstract
Abstract
Abstract More than 50 diseases are associated with a conversion of proteins or peptides from their soluble functional states to highly organized fibrillar aggregates called amyloid fibrils. Due to the specific physico-chemical properties, specifically designed iron oxide nanoparticles may be an effective strategy for inhibiting the amyloid fibrillization of proteins. The inhibitory effect of three types of iron oxide nanoparticles coated with differently modified dextran on lysozyme fibrils formation was studied by Thioflavin T assay and atomic force microscopy. The size and zeta potential of studied nanoparticles were determined by dynamic light scattering. It had been found that nanoparticles are able to inhibit formation of lysozyme amyloid aggregates in concentration-dependent manner. Our results suggest that size of nanoparticles influenced the extent of their inhibitory properties. Moreover, the most effective nanoparticles were not toxic after 48 h incubation with neuroblastoma SH-SY5Y cell line at concentration close to IC50 values.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Nanoparticle-Based Drug Delivery · Proteins in Food Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Protein misfolding, functional amyloid, and human disease10.1146/annurev.biochem.75.101304.123901 ↗
2. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution10.1007/s00109-003-0464-5 ↗
3. Mechanisms of protein aggregation10.2174/138920109788488932 ↗
4. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vivo10.3109/13506129709003833 ↗
5. Thermodynamic versus conformational metastability in fibril-forming lysozyme solutions10.1021/jp303430g ↗
6. Effect of surfaces on amyloid fibril formation10.1371/journal.pone.0025954 ↗
7. Effect of nanoparticles on protein folding and fibrillogenesis10.3390/ijms10020646 ↗
8. The effect of nanoparticles on amyloid aggregation depends on the protein stability and intrinsic aggregation rate10.1021/la203078w ↗
9. Applications of nanoparticles in biology and medicine10.1186/1477-3155-2-3 ↗
10. A three-stage kinetic model of amyloid fibrillation10.1529/biophysj.106.098608 ↗
11. Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation10.1021/cn900027u ↗
12. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles10.1021/ja8041806 ↗
13. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications10.1021/cr068445e ↗
14. Synthesis and characterization of fluorinated magnetic core–shell nanoparticles for inhibition of insulin amyloid fibril formation10.1088/0957-4484/20/22/225106 ↗
15. Effect of Fe3O4 magnetic nanoparticles on lysozyme amyloid aggregation10.1088/0957-4484/21/6/065103 ↗
16. Depolymerization of insulin amyloid fibrils by albumin-modified magnetic fluid10.1088/0957-4484/23/5/055101 ↗
17. The molecular mass of dextran used to modify magnetite nanoparticles affects insulin amyloid aggregation10.1016/j.jmmm.2016.10.083 ↗
18. Cellular uptake and toxicity of Au55 clusters10.1002/smll.200500104 ↗
19. In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines10.1007/s00449-009-0354-5 ↗
20. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles10.1016/j.biomaterials.2004.05.022 ↗
21. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite10.1016/j.biomaterials.2005.02.036 ↗
22. Insights into kinetics of agitation-induced aggregation of hen lysozyme under heat and acidic conditions from various spectroscopic methods10.1371/journal.pone.0142095 ↗
23. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress10.2147/IJN.S13244 ↗